The funds will facilitate the clinical progression of ABO-101, the company’s lead therapeutic candidate targeting PH1.

Advancements in genome editing, particularly CRISPR, are reshaping precision biology, driving innovations in medicine, agriculture, and synthetic biology.

Explore the Genome Editing Market size, share, trends, and future growth. Learn about CRISPR, TALENs, ZFNs, and advancements shaping genetic research & medicine.

Researchers at Kumamoto University have successfully executed a practical trial of a new genome-editing technique that allows ...

Shortly after this publication, Bogdanove struck up a collaboration with Daniel Voytas, a plant geneticist at the University ...

Researchers are using gene editing techniques to introduce beneficial traits like polled and disease resistance, as well as ...

The growing occurrence of genetic disorders like sickle cell anemia, cystic fibrosis, and muscular dystrophy is fueling the demand for gene therapy and genome editing solutions, as these approaches ...

The International Symposium on “Harnessing Genome Editing for Resilient Agriculture” concluded at the Gurdev Singh Khush ...

This study presents an enhanced nuclease prime editor (uPEn) that significantly improves gene knock-in and knockout ...

Ludhiana: The international symposium on harnessing genome editing for resilient agriculture successfully concluded at the ...

Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investorsFinancing extends Arbor’s cash ...

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...